These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. Morita K; Ihnken K; Buckberg GD; Sherman MP; Young HH; Ignarro LJ J Clin Invest; 1994 Jun; 93(6):2658-66. PubMed ID: 8201004 [TBL] [Abstract][Full Text] [Related]
7. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XIII. Interaction between oxygen tension and cardioplegic composition in limiting nitric oxide production and oxidant damage. Ihnken K; Morita K; Buckberg GD; Sherman MP; Ignarro LJ; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1274-86. PubMed ID: 7475179 [TBL] [Abstract][Full Text] [Related]
8. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis: a new concept of controlled cardiac reoxygenation. Morita K; Ihnken K; Buckberg GD J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1265-73. PubMed ID: 7475178 [TBL] [Abstract][Full Text] [Related]
9. Studies of hypoxemic/reoxygenation injury: with aortic clamping. X. Exogenous antioxidants to avoid nullification of the cardioprotective effects of blood cardioplegia. Morita K; Ihnken K; Buckberg GD; Matheis G; Sherman MP; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1245-54. PubMed ID: 7475176 [TBL] [Abstract][Full Text] [Related]
10. Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. Ihnken K; Morita K; Buckberg GD; Sherman MP; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1182-9. PubMed ID: 7475169 [TBL] [Abstract][Full Text] [Related]
11. Studies of hypoxemic/reoxygenation injury: without aortic clamping. V. Role of the L-arginine-nitric oxide pathway: the nitric oxide paradox. Morita K; Sherman MP; Buckberg GD; Ihnken K; Matheis G; Young HH; Ignarro LJ J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1200-11. PubMed ID: 7475171 [TBL] [Abstract][Full Text] [Related]
12. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate. Morita K; Ihnken K; Buckberg GD; Matheis G; Sherman MP; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1228-34. PubMed ID: 7475174 [TBL] [Abstract][Full Text] [Related]
13. Studies of hypoxemic/reoxygenation injury with aortic clamping: XI. Cardiac advantages of normoxemic versus hyperoxemic management during qardiopulmonary bypass. Ihnken K; Morita K; Buckberg GD; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1255-64. PubMed ID: 7475177 [TBL] [Abstract][Full Text] [Related]
14. Surgical reoxygenation injury of the myocardium in cyanotic patients: clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass. Morita K Gen Thorac Cardiovasc Surg; 2012 Sep; 60(9):549-56. PubMed ID: 22782441 [TBL] [Abstract][Full Text] [Related]
15. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VII. Counteraction of oxidant damage by exogenous antioxidants: coenzyme Q10. Morita K; Ihnken K; Buckberg GD; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1221-7. PubMed ID: 7475173 [TBL] [Abstract][Full Text] [Related]
16. Studies of hypoxemic/reoxygenation injury: without aortic clamping. II. Evidence for reoxygenation damage. Ihnken K; Morita K; Buckberg GD; Matheis G; Sherman MP; Allen BS; Young HH J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1171-81. PubMed ID: 7475168 [TBL] [Abstract][Full Text] [Related]